Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1799PDF: 838HTML: 182 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1516PDF: 801Suppl. Files: 337Html: 141 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2366PDF: 1192HTML: 687 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1606PDF: 808HTML: 223 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4873PDF: 1856HTML: 2170 -
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
237PDF: 272Suppl. Files: 48HTML: 54 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1213PDF: 775HTML: 1492Figure 1: 196Figure 2: 198 -
Osteolytic bone lesions – A rare presentation of AML M6.
2023PDF: 1125HTML: 7957Untitled: 207 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2920PDF: 1127HTML: 3039 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2682PDF: 763HTML: 2319 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1135PDF: 453HTML: 254 -
How I treat acute and persistent sickle cell pain
2009PDF: 1132HTML: 495 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1102PDF: 1211HTML: 101 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1303PDF: 781HTML: 327 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3421PDF: 2296HTML: 23375Untitled: 214Untitled: 227Untitled: 242 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1424PDF: 564HTML: 212 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2081PDF: 784HTML: 3119 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1435PDF: 838HTML: 3125 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12563PDF: 1699HTML: 4232Cover letter: 209Figure 1: 216 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1673PDF: 604HTML: 238 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3625PDF: 1540HTML: 4442CoverLetter: 191Figure1: 204







